Company ' s Update on its Activity in Research and Development and FDA interactions On February 26, 2024, the Company announced the latest findings from the Company's pharmacokinetic study of its ...

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University of Texas Medical Branch and the biotechnology company Moderna to develop an ...

Dr. Stephen Byrn, CSO of Improved Pharma remarked about the importance of this research. "Lauren's prior research experience with SLNs is critical for our success. As the industry moves forward ...

The global Formulation Development Outsourcing Market is projected to grow from US$ 33.6 billion in 2024 to US$ 64.74 billion ...

Another world leader in pharma and biotechnology has partnered with GenerativeX to extend its reach with front-line physicians. Generative AI analyzes relevant data from research articles ...

As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.” Advertisement ...

About FSD Pharma FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary, is focused on ...

With more than 650 publishing partners, Research and Markets stands apart as a trusted advocate for its clients. It helps global pharmaceutical companies navigate a fragmented, often confusing ...

By Adria Calatayud Roche Holding said Johannes Clevers, head of pharmaceutical research and early development, will retire from the company after three years in the role. Clevers, who was also ...

The first component, with an outlay of ₹ 700 crore, aims to set up Centres of Excellence (CoEs) at seven National Institutes of Pharmaceutical Education and Research (NIPERs). This will focus on ...